| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589957 Compounds and methods of use for treatment of neurogenic inflammation |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/08/2003 | CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053938A1 Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | WO2003053437A1 Triazoles as oxytocin antagonists |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053344A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2002101073A3 Aryl-benzimidazole compounds having antiinfective activity |
| 07/03/2003 | WO2002079147B1 Inhibitors of prenyl-protein transferase |
| 07/03/2003 | US20030125370 Treating or preventing protein kinase related disorders in a organism, such as cancer, diabetes, autoimmune disoders, hyperproliferation diosrders, osteoarthritis, rhematoid arthritis, angiogenesis, immunological disorders |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125330 Anxiolytics and antidepressants |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125317 Vitronectin receptor antagonists |
| 07/03/2003 | US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | CA2471355A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | CA2471083A1 Benzhydryl derivatives |
| 07/03/2003 | CA2469042A1 Triazoles as oxytocin antagonists |
| 07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 07/02/2003 | EP1322710A1 Modified carbocyanine dyes and their conjugates |
| 07/02/2003 | EP1322646A1 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity |
| 07/02/2003 | EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa |
| 07/02/2003 | EP1322640A1 Heteroaryl substituted hydroxyphenyltriazine uv-absorbers |
| 07/02/2003 | EP1322639A1 Substituted aryl ketones and their use as herbicides |
| 07/02/2003 | EP1322638A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 07/02/2003 | EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 07/02/2003 | EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427824A Indole derivatives, process for preparation of same and use thereof |
| 07/02/2003 | CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 07/02/2003 | CN1113060C Substituted 2-amino-4-alkylamino-1,3,5-triazine as herbicide |
| 07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
| 07/01/2003 | US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 07/01/2003 | US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction |
| 07/01/2003 | US6586594 Reacting 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl) ethanone and 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine in the presence of zinc, iodine, lewis acids, aprotic solvents and optionally lead to form sterospecific fungicides |
| 07/01/2003 | US6586447 Farnesyl protein transferase inhibitors such as 4-(6-(4-Cyano -phenyl)-3,3-bis-(1H-imidazol-4-ylmethyl)-2-oxo-2,3- dihydro-indol-1-ylmethyl)-N,N-dimethyl benzenesulfonamide used as anticarcinogenic agents |
| 07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
| 07/01/2003 | US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/01/2003 | US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders |
| 07/01/2003 | US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 07/01/2003 | US6586368 Condensed heterocylic compounds and herbicides containing them |
| 06/26/2003 | WO2003051883A1 Indole derivative |
| 06/26/2003 | WO2003051873A1 Piperazine compounds and their phamaceutical use |
| 06/26/2003 | WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
| 06/26/2003 | WO2003051866A1 2-guanidino-4-heterocyclylquinazolines |
| 06/26/2003 | WO2003051847A1 (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors |
| 06/26/2003 | WO2003051846A2 Substituted phenyl derivatives |
| 06/26/2003 | WO2003051845A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 06/26/2003 | WO2003051838A2 Protein kinase inhibitors |
| 06/26/2003 | WO2003051833A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 06/26/2003 | WO2003051831A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 06/26/2003 | WO2003051366A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 06/26/2003 | WO2003051359A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 06/26/2003 | WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/26/2003 | WO2003051277A2 Novel compounds |
| 06/26/2003 | WO2003051275A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | WO2003040109A3 Quinazoline derivatives as antitumor agents |
| 06/26/2003 | US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants |
| 06/26/2003 | US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction |
| 06/26/2003 | US20030120070 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 06/26/2003 | US20030119896 Chondrogenesis promoters and indolin-2-one derivatives |
| 06/26/2003 | US20030119895 Anticancer agents |
| 06/26/2003 | US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene |
| 06/26/2003 | US20030119873 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |